Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2019

Open Access 01-12-2019 | Non-Invasive Ventilation | Study protocol

Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial

Authors: Nicholas A. Barrett, Eirini Kostakou, Nicholas Hart, Abdel Douiri, Luigi Camporota

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a common cause of chronic respiratory failure and its course is punctuated by a series of acute exacerbations which commonly lead to hospital admission. Exacerbations are managed through the application of non-invasive ventilation and, when this fails, tracheal intubation and mechanical ventilation. The need for mechanical ventilation significantly increases the risk of death. An alternative therapy, extracorporeal carbon dioxide removal (ECCO2R), has been shown to be efficacious in removing carbon dioxide from the blood; however, its impact on respiratory physiology and patient outcomes has not been explored.

Methods/design

A randomised controlled open label trial of patients (12 in each arm) with acute exacerbations of COPD at risk of failing conventional therapy (NIV) randomised to either remaining on NIV or having ECCO2R added to NIV with a primary endpoint of time to cessation of NIV. The change in respiratory physiology following the application of ECCO2R and/or NIV will be measured using electrical impedance tomography, oesophageal pressure and parasternal electromyography. Additional outcomes, including patient tolerance, outcomes, need for readmission, changes in blood gases and biochemistry and procedural complications, will be measured. Physiological changes will be compared within one patient over time and between the two groups. Healthcare costs in the UK system will also be compared between the two groups.

Discussion

COPD is a common disease and exacerbations are a leading cause of hospital admission in the UK and worldwide, with a sizeable mortality. The management of patients with COPD consumes significant hospital and financial resources. This study seeks to understand the feasibility of a novel approach to the management of patients with acute exacerbations of COPD as well as to understand the underlying physiological changes to explain why the approach does or does not assist this patient cohort. Detailed respiratory physiology has not been previously undertaken using this technique and there are no other randomised controlled trials currently in the literature.

Trial registration

ClinicalTrials.gov, NCT02086084.
Appendix
Available only for authorised users
Literature
1.
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.PubMedCrossRef
2.
Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23(5):698–702.PubMedCrossRef
3.
Kessler R, Stahl E, Vogelmeier C, Haughney J, Trudeau E, Lofdahl CG, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest. 2006;130(1):133–42.PubMedCrossRef
4.
Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–5.PubMedPubMedCentralCrossRef
5.
Anzueto A. Impact of exacerbations on COPD. Eur Respir Rev. 2009;19(116):113–8.CrossRef
6.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.PubMedCrossRef
7.
Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–52.PubMedPubMedCentralCrossRef
8.
9.
Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–13.PubMedCrossRef
10.
Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV (1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164(3):358–64.PubMedCrossRef
11.
Kesten S, Celli B, Decramer M, Liu D, Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial. Respir Res. 2011;12:129.PubMedPubMedCentralCrossRef
12.
Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–51.PubMedPubMedCentral
13.
Ankjaergaard KL, Rasmussen DB, Schwaner SH, Andreassen HF, Hansen EF, Wilcke JT. COPD: Mortality and readmissions in relation to number of admissions with noninvasive ventilation. Copd. 2017;14(1):30–6.PubMedCrossRef
14.
Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s.PubMedCrossRef
15.
16.
Osadnik CR, Tee VS, Carson-Chahhoud KV, Picot J, Wedzicha JA, Smith BJ. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:Cd004104.PubMed
17.
18.
Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333(13):817–22.PubMedCrossRef
19.
Lightowler JV, Wedzicha JA, Elliott MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003;326(7382):185.PubMedPubMedCentralCrossRef
20.
Appendini L, Patessio A, Zanaboni S, Carone M, Gukov B, Donner C. Physiologic effects of positive endexpiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;149(5):1069–76.PubMedCrossRef
21.
Demoule A, Girou E, Richard JC, Taille S, Brochard L. Increased use of noninvasive ventilation in French intensive care units. Intensive Care Med. 2006;32(11):1747–55.PubMedCrossRef
22.
Abroug F, Ouanes-Besbes L, Hammouda Z, Benabidallah S, Dachraoui F, Ouanes I, et al. Noninvasive ventilation with helium-oxygen mixture in hypercapnic COPD exacerbation: aggregate meta-analysis of randomized controlled trials. Ann Intensive Care. 2017;7(1):59.PubMedPubMedCentralCrossRef
23.
Ozsancak Ugurlu A, Habesoglu MA. Epidemiology of NIV for acute respiratory failure in COPD patients: Results from the international surveys vs. the "real world". Copd. 2017;14(4):429–38.PubMedCrossRef
24.
Contou D, Fragnoli C, Cordoba-Izquierdo A, Boissier F, Brun-Buisson C, Thille AW. Noninvasive ventilation for acute hypercapnic respiratory failure: intubation rate in an experienced unit. Respir Care. 2013;58(12):2045–52.PubMedCrossRef
25.
Carratu P, Bonfitto P, Dragonieri S, Schettini F, Clemente R, Di Gioia G, et al. Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation. Eur J Clin Investig. 2005;35(6):404–9.CrossRef
26.
Kumar S, Khilnani GC, Banga A, Sharma SK. Predictors of requirement of mechanical ventilation in patients with chronic obstructive pulmonary disease with acute respiratory failure. Lung India. 2013;30(3):178–82.PubMedPubMedCentralCrossRef
27.
Confalonieri M, Garuti G, Cattaruzza MS, Osborn JF, Antonelli M, Conti G, et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J. 2005;25(2):348–55.PubMedCrossRef
28.
Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med. 2012;185(2):152–9.PubMedPubMedCentralCrossRef
29.
Martin-Gonzalez F, Gonzalez-Robledo J, Sanchez-Hernandez F, Moreno-Garcia MN, Barreda-Mellado I. Effectiveness and predictors of failure of noninvasive mechanical ventilation in acute respiratory failure. Med Intensiva. 2016;40(1):9–17.PubMedCrossRef
30.
Barrett NA, Camporota L. The evolving role and practical application of extracorporeal carbon dioxide removal in critical care. Crit Care Resusc. 2017;19(Suppl 1):62–7.PubMed
31.
Camporota L, Barrett N. Current applications for the use of extracorporeal carbon dioxide removal in critically ill patients. Biomed Res Int. 2016;2016:9781695.PubMedPubMedCentralCrossRef
32.
Batchinsky AI, Jordan BS, Regn D, Necsoiu C, Federspiel WJ, Morris MJ, et al. Respiratory dialysis: reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal. Crit Care Med. 2011;39(6):1382–7.PubMedCrossRef
33.
Wearden PD, Federspiel WJ, Morley SW, Rosenberg M, Bieniek PD, Lund LW, et al. Respiratory dialysis with an active-mixing extracorporeal carbon dioxide removal system in a chronic sheep study. Intensive Care Med. 2012;38(10):1705–11.PubMedPubMedCentralCrossRef
34.
Ruberto F, Pugliese F, D'Alio A, Perrella S, D'Auria B, Ianni S, et al. Extracorporeal removal CO2 using a venovenous, low-flow system (Decapsmart) in a lung transplanted patient: a case report. Transplant Proc. 2009;41(4):1412–4.PubMedCrossRef
35.
Cardenas VJ Jr, Lynch JE, Ates R, Miller L, Zwischenberger JB. Venovenous carbon dioxide removal in chronic obstructive pulmonary disease: experience in one patient. ASAIO J. 2009;55(4):420–2.PubMedCrossRef
36.
Dorrington KL, McRae KM, Gardaz JP, Dunnill MS, Sykes MK, Wilkinson AR. A randomized comparison of total extracorporeal CO2 removal with conventional mechanical ventilation in experimental hyaline membrane disease. Intensive Care Med. 1989;15(3):184–91.PubMedCrossRef
37.
Livigni S, Maio M, Ferretti E, Longobardo A, Potenza R, Rivalta L, et al. Efficacy and safety of a low-flow veno-venous carbon dioxide removal device: results of an experimental study in adult sheep. Crit Care. 2006;10(5):R151.PubMedPubMedCentralCrossRef
38.
39.
Moss CE, Galtrey EJ, Camporota L, Meadows C, Gillon S, Ioannou N, et al. A retrospective observational case series of low-flow venovenous extracorporeal carbon dioxide removal use in patients with respiratory failure. ASAIO J. 2016;62(4):458–62.PubMedCrossRef
40.
Garcia JP, Kon ZN, Evans C, Wu Z, Iacono AT, McCormick B, et al. Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls. J Thorac Cardiovasc Surg. 2011;142(4):755–61.PubMedCrossRef
41.
Kluge S, Braune SA, Engel M, Nierhaus A, Frings D, Ebelt H, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med. 2012;38(10):1632–9.PubMedCrossRef
42.
Burki NK, Mani RK, Herth FJ, Schmidt W, Teschler H, Bonin F, et al. A novel extracorporeal CO2 removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest. 2013;143(3):678–86.PubMedCrossRef
43.
Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S, et al. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med. 2016;42(9):1437–44.PubMedCrossRef
44.
Abrams D, Brodie D. Emerging indications for extracorporeal membrane oxygenation in adults with respiratory failure. Ann Am Thorac Soc. 2013;10(4):371–7.PubMedCrossRef
45.
Sklar MC, Beloncle F, Katsios CM, Brochard L, Friedrich JO. Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med. 2015;41(10):1752–62.PubMedCrossRef
46.
Pisani L, Fasano L, Corcione N, Comellini V, Guerrieri A, Ranieri MV, et al. Effects of extracorporeal CO2 removal on inspiratory effort and respiratory pattern in patients who fail weaning from mechanical ventilation. Am J Respir Crit Care Med. 2015;192(11):1392–4.PubMedCrossRef
47.
48.
Bayford R. Bioimpedance tomography (electrical impedance tomography). Annu Rev Biomed Eng. 2006;8:63–91.PubMedCrossRef
49.
50.
Bodenstein M, David M, Markstaller K. Principles of electrical impedance tomography and its clinical application. Crit Care Med. 2009;37(2):713–24.PubMedCrossRef
51.
Frerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2016. https://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​27596161.
52.
53.
Costa EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009;15(1):18–24.PubMedCrossRef
54.
Moerer O, Hahn G, Quintel M. Lung impedance measurements to monitor alveolar ventilation. Curr Opin Crit Care. 2011;17(3):260–7.PubMedCrossRef
55.
Muders T, Luepschen H, Putensen C. Impedance tomography as a new monitoring technique. Curr Opin Crit Care. 2010;16(3):269–75.PubMedCrossRef
56.
Bikker IG, Preis C, Egal M, Bakker J, Gommers D. Electrical impedance tomography measured at two thoracic levels can visualize the ventilation distribution changes at the bedside during a decremental positive end-expiratory lung pressure trial. Crit Care. 2011;15(4):R193.PubMedPubMedCentralCrossRef
57.
Laghi F, Goyal A. Auto-PEEP in respiratory failure. Minerva Anestesiol. 2012;78(2):201–21.PubMed
58.
Brandolese R, Broseghini C, Polese G, Bernasconi M, Brandi G, Milic-Emili J, et al. Effects of intrinsic PEEP on pulmonary gas exchange in mechanically-ventilated patients. Eur Respir J. 1993;6(3):358–63.PubMed
59.
Balleza M, Calaf N, Feixas T, Gonzalez M, Anton D, Riu PJ, et al. Measuring breathing pattern in patients with chronic obstructive pulmonary disease by electrical impedance tomography. Archivos de bronconeumologia. 2009;45(7):320–4.PubMedCrossRef
60.
Trenk F, Mendes L, Carvalho P, Paiva RP, Henriques J, Maglaveras N, et al. Evaluation of lung ventilation distribution in chronic obstructive pulmonary disease patients using the global inhomogeneity index. Conf Proc IEEE Eng Med Biol Soc. 2016;2016:5286–9.
61.
Vogt B, Pulletz S, Elke G, Zhao Z, Zabel P, Weiler N, et al. Spatial and temporal heterogeneity of regional lung ventilation determined by electrical impedance tomography during pulmonary function testing. J Appl Physiology (1985). 2012;113(7):1154–61.CrossRef
62.
Vogt B, Zhao Z, Zabel P, Weiler N, Frerichs I. Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2016;311(1):L8–l19.PubMedCrossRef
63.
Mauri T, Bellani G, Salerno D, Mantegazza F, Pesenti A. Regional distribution of air trapping in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(12):1466–7.PubMedCrossRef
64.
Kostakou E, Barrett N, Camporota L. Electrical impedance tomography to determine optimal positive end-expiratory pressure in severe chronic obstructive pulmonary disease. Crit Care. 2016:1–2.
65.
Crabb M, Grychtol B, Lionheart W, Camporota L, editors. EIT regional time constants. 2016.
66.
R’oka P, Waldmann A, Ender F, Bohm S, Windisch W, Strassmann S, et al. Expiratory time constants by electrical impedance tomography in hypoxemic and hypercapnic acute lung failure - a feasibility study. Int Care Med Exp. 2015;3(Supp 1):495.
67.
Mauri T, Bellani G, Confalonieri A, Tagliabue P, Turella M, Coppadoro A, et al. Topographic distribution of tidal ventilation in acute respiratory distress syndrome: effects of positive end-expiratory pressure and pressure support. Crit Care Med. 2013;41(7):1664–73.PubMedCrossRef
68.
Frerichs I, Dargaville PA, Dudykevych T, Rimensberger PC. Electrical impedance tomography: a method for monitoring regional lung aeration and tidal volume distribution? Intensive Care Med. 2003;29(12):2312–6.PubMedCrossRef
69.
70.
Miedema M, de Jongh FH, Frerichs I, van Veenendaal MB, van Kaam AH. Regional respiratory time constants during lung recruitment in high-frequency oscillatory ventilated preterm infants. Intensive Care Med. 2012;38(2):294–9.PubMedCrossRef
71.
Becher T, Kott M, Schadler D, Vogt B, Meinel T, Weiler N, et al. Influence of tidal volume on ventilation inhomogeneity assessed by electrical impedance tomography during controlled mechanical ventilation. Physiol Meas. 2015;36(6):1137–46.PubMedCrossRef
72.
Becher T, Vogt B, Kott M, Schadler D, Weiler N, Frerichs I. Functional regions of interest in electrical impedance tomography: A secondary analysis of two clinical studies. PLoS One. 2016;11(3):e0152267.PubMedPubMedCentralCrossRef
73.
Zhao Z, Moller K, Steinmann D, Frerichs I, Guttmann J. Evaluation of an electrical impedance tomography-based Global Inhomogeneity Index for pulmonary ventilation distribution. Intensive Care Med. 2009;35(11):1900–6.PubMedCrossRef
74.
Zhao Z, Pulletz S, Frerichs I, Muller-Lisse U, Moller K. The EIT-based global inhomogeneity index is highly correlated with regional lung opening in patients with acute respiratory distress syndrome. BMC Res Notes. 2014;7:82.PubMedPubMedCentralCrossRef
75.
Frerichs I, Achtzehn U, Pechmann A, Pulletz S, Schmidt EW, Quintel M, et al. High-frequency oscillatory ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease. J Crit Care. 2012;27(2):172–81.PubMedCrossRef
76.
Riedel T, Kyburz M, Latzin P, Thamrin C, Frey U. Regional and overall ventilation inhomogeneities in preterm and term-born infants. Intensive Care Med. 2009;35(1):144–51.PubMedCrossRef
77.
Wrigge H, Zinserling J, Muders T, Varelmann D, Gunther U, von der Groeben C, et al. Electrical impedance tomography compared with thoracic computed tomography during a slow inflation maneuver in experimental models of lung injury. Crit Care Med. 2008;36(3):903–9.PubMedCrossRef
78.
Frerichs I, Zhao Z, Becher T, Zabel P, Weiler N, Vogt B. Regional lung function determined by electrical impedance tomography during bronchodilator reversibility testing in patients with asthma. Physiol Meas. 2016;37(6):698–712.PubMedCrossRef
79.
Jolley CJ, Luo YM, Steier J, Rafferty GF, Polkey MI, Moxham J. Neural respiratory drive and breathlessness in COPD. Eur Respir J. 2015;45(2):355–64.PubMedCrossRef
80.
Murphy PB, Kumar A, Reilly C, Jolley C, Walterspacher S, Fedele F, et al. Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD. Thorax. 2011;66(7):602–8.PubMedCrossRef
81.
Suh ES, Mandal S, Harding R, Ramsay M, Kamalanathan M, Henderson K, et al. Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD. Thorax. 2015;70(12):1123–30.PubMedCrossRef
82.
Petit JM, Milic-Emili G, Delhez L. Role of the diaphragm in breathing in conscious normal man: an electromyographic study. J Appl Physiol. 1960;15:1101–6.PubMedCrossRef
83.
Sinderby C, Spahija J, Beck J. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1637–41.PubMedCrossRef
84.
Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev. 2009;18(112):66–79.PubMedCrossRef
85.
Steier J, Jolley CJ, Polkey MI, Moxham J. Nocturnal asthma monitoring by chest wall electromyography. Thorax. 2011;66(7):609–14.PubMedCrossRef
86.
Fukuda T, Echeimberg J, Pompeu J, Lucareli P, Garbelotti S, Gimenes R, et al. Root mean square value of the electromyographic signal in the isometric torque of the quadriceps, hamstrings and brachial biceps muscles in female subjects. J Appl Res. 2010;10(1):32–9.
87.
Fridlund AJ, Cacioppo JT. Guidelines for human electromyographic research. Psychophysiology. 1986;23(5):567–89.PubMedCrossRef
88.
Benditt JO. Esophageal and gastric pressure measurements. Respir Care. 2005;50(1):68–75 discussion −7.PubMed
89.
Bellani G, Pesenti A. Assessing effort and work of breathing. Curr Opin Crit Care. 2014;20(3):352–8.PubMedCrossRef
90.
Hedenstierna G. Esophageal pressure: benefit and limitations. Minerva Anestesiol. 2012;78(8):959–66.PubMed
91.
Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, et al. The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014;189(5):520–31.PubMedCrossRef
92.
Brochard L. Measurement of esophageal pressure at bedside: pros and cons. Curr Opin Crit Care. 2014;20(1):39–46.PubMedCrossRef
93.
Baydur A, Behrakis PK, Zin WA, Jaeger M, Milic-Emili J. A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis. 1982;126(5):788–91.PubMed
94.
Cummins C, Bentley AH, McAuley DF, McNamee JJ, Patrick H, Barrett NA. A United Kingdom Register study of in-hospital outcomes of patients receiving extracorporeal carbon dioxide removal. J Intensive Care Soc. 2018;19(2):114–21.PubMedCrossRef
95.
NICE. National Institute for Health and Care Excellence Interventional Procedure Guidance 428. London: Extracorporeal membrane carbon dioxide removal; 2012.
Metadata
Title
Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial
Authors
Nicholas A. Barrett
Eirini Kostakou
Nicholas Hart
Abdel Douiri
Luigi Camporota
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3548-4

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue

Study protocol

Effect of home-based transcranial direct current stimulation (tDCS) on cognitive function in patients with mild cognitive impairment: a study protocol for a randomized, double-blind, cross-over study

Research

Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel

Research

Cost analysis and efficacy of recruitment strategies used in a large pragmatic community-based clinical trial targeting low-income seniors: a comparative descriptive analysis

Study protocol

Retrograde Inferior Vena caval Perfusion for Total Aortic arch Replacement Surgery (RIVP-TARS): study protocol for a multicenter, randomized controlled trial

Methodology

Involving people living with dementia in research: an accessible modified Delphi survey for core outcome set development

Study protocol

Jin’s three-needle acupuncture technique for chronic fatigue syndrome: a study protocol for a multicentre, randomized, controlled trial